HBV News and Research

RSS
4 in 10 cancers preventable by adopting simple lifestyle changes

4 in 10 cancers preventable by adopting simple lifestyle changes

Texas Biomedical Research Institute tests promising new treatment for HBV infection

Texas Biomedical Research Institute tests promising new treatment for HBV infection

Daily aspirin therapy linked to reduced risk of HBV‐related liver cancer

Daily aspirin therapy linked to reduced risk of HBV‐related liver cancer

Report sheds light on global market for infectious disease immunoassays

Report sheds light on global market for infectious disease immunoassays

Shortage of Hepatitis B vaccine - prioritization of vaccinations announced in UK

Shortage of Hepatitis B vaccine - prioritization of vaccinations announced in UK

FDA approves new treatment for all HCV genotypes 1-6

FDA approves new treatment for all HCV genotypes 1-6

U.S. FDA approves updated labeling for pan-genotypic single tablet regimen for HCV/HIV co-infected patients

U.S. FDA approves updated labeling for pan-genotypic single tablet regimen for HCV/HIV co-infected patients

World Hepatitis Day – gearing towards eliminating viral hepatitis by 2030

World Hepatitis Day – gearing towards eliminating viral hepatitis by 2030

ECDC highlights need to scale-up efforts for eliminating viral hepatitis in Europe

ECDC highlights need to scale-up efforts for eliminating viral hepatitis in Europe

Princeton scientists test cell-culture system to aid study of HBV infections

Princeton scientists test cell-culture system to aid study of HBV infections

FDA approves fixed-dose combination tablet for treating adults with chronic hepatitis C

FDA approves fixed-dose combination tablet for treating adults with chronic hepatitis C

Study estimates number of cancer deaths in China attributable to potentially modifiable risk factors

Study estimates number of cancer deaths in China attributable to potentially modifiable risk factors

Survey finds wide variation in hepatitis B, C testing policy and practice across the EU/EEA

Survey finds wide variation in hepatitis B, C testing policy and practice across the EU/EEA

Statins may provide favorable effects in patients with HBV- or HCV-related cirrhosis

Statins may provide favorable effects in patients with HBV- or HCV-related cirrhosis

Study reveals promising results for primary liver cancer patients treated with SIR-Spheres Y-90 resin microspheres

Study reveals promising results for primary liver cancer patients treated with SIR-Spheres Y-90 resin microspheres

Statins may provide favorable outcomes to patients with HBV- or HCV-related cirrhosis

Statins may provide favorable outcomes to patients with HBV- or HCV-related cirrhosis

WHO Global Hepatitis Report reveals goal to eliminate viral hepatitis by 2030

WHO Global Hepatitis Report reveals goal to eliminate viral hepatitis by 2030

FDA grants approval for two drugs to treat hepatitis C virus in children

FDA grants approval for two drugs to treat hepatitis C virus in children

ECDC guidance aims to improve antenatal screening for infections to avoid mother-to-child transmission

ECDC guidance aims to improve antenatal screening for infections to avoid mother-to-child transmission

Quest Diagnostics introduces new HBV test service to help evaluate patient’s response to drug therapies

Quest Diagnostics introduces new HBV test service to help evaluate patient’s response to drug therapies